The United Nations World Food Programme (WFP) is extending its partnership with the Novo Nordisk Foundation, through a ...

Novo Holdings, the controlling shareholder of weight loss drugmaker Novo Nordisk A/S (NYSE ... Novo Holdings CEO Kasim Kutay called 2024 “a very strong year” since the portfolio generated ...

Novo Nordisk has announced major leadership changes, with EVP Camilla Sylvest departing and Ludovic Helfgott taking on an ...

Novo Nordisk's market value has roughly halved since July 2024, partly because of investor concern that it has lost its first-mover advantage in the fiercely competitive obesity drug market to U.S ...